14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

Journal article

Peer reviewed

R. Komrokji, G. Garcia-Manero, L. Ades, A. Laadem, B. Vo, T. Prebet, A. Stamatoullas, T. Boyd, J. Delaunay, D.P. Steensma, …

Leukemia research, Vol.39, pp.S5-S6

2015-04

Metrics

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.225 Hematologic Diseases; 1.225.626 Sickle Cell Disease
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION
Creators: R. Komrokji
G. Garcia-Manero
L. Ades
A. Laadem
B. Vo
T. Prebet
A. Stamatoullas
T. Boyd
J. Delaunay
D.P. Steensma
M.A. Sekeres
O. Beyne-Rauzy
J. Zou
K.M. Attie
M.L. Sherman
P. Fenaux
A.F. List
Publication Details: Leukemia research, Vol.39, pp.S5-S6
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757810202976